IDH1 gene mutations: a new paradigm in glioma prognosis and therapy? | Oncologist;15(2): 196-9, 2010. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

Virtual Health Library

United States - Mexico Border

Subject descriptor lookup Advanced Search

IDH1 gene mutations: a new paradigm in glioma prognosis and therapy?

Labussiere, Marianne; Sanson, Marc; Idbaih, Ahmed; Delattre, Jean-Yves.

Affiliation

Labussiere M; CRICM INSERM UMR 975, Biologie des Interactions Neurones-Glie, Groupe Hospitalier Pitié-Salpêtrière, Paris, France. marianne.labussiere@voila.fr

Oncologist ; 15(2): 196-9, 2010.

Article in En | MEDLINE | ID: mdl-20133500

Subject(s)

Brain Neoplasms/genetics; Brain Neoplasms/therapy; Glioma/genetics; Glioma/therapy; Isocitrate Dehydrogenase/genetics; Point Mutation; Brain Neoplasms/enzymology; Glioblastoma/enzymology; Glioblastoma/genetics; Glioblastoma/therapy; Glioma/enzymology; Humans; Prognosis

Search on Google

Full text: 1 Database: MEDLINE Main subject: Brain Neoplasms / Point Mutation / Glioma / Isocitrate Dehydrogenase Type of study: Prognostic_studies Limits: Humans Language: En Year: 2010 Type: Article

Search on Google

Full text: 1 Database: MEDLINE Main subject: Brain Neoplasms / Point Mutation / Glioma / Isocitrate Dehydrogenase Type of study: Prognostic_studies Limits: Humans Language: En Year: 2010 Type: Article